Last reviewed · How we verify
Sulfamethazine (sulfadimidine)
Sulfamethazine (generic name: sulfadimidine) is a sulfadimidine drug developed by Pfizer. It is currently FDA-approved (first approved 1949).
At a glance
| Generic name | sulfadimidine |
|---|---|
| Sponsor | Pfizer |
| Drug class | sulfadimidine |
| Target | Lactoylglutathione lyase, Dihydropteroate synthase |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
| First approval | 1949 |
Approved indications
Common side effects
Drug interactions
- methotrexate
- pralatrexate
Key clinical trials
- Tele-video to Improve Daily Activity 2.0 (NA)
- Families Moving Together Curriculum (NA)
- Platelet Rich Plasma Injections In Young And Old Human Subjects (PHASE2)
- Research on Circulation Management Strategy Based on Oxygen Metabolism Balance After CHD Surgery (NA)
- TBI Evaluation and Management (TEaM) (NA)
- PA Moves Trial - PCP Participants (NA)
- Enhancing Quality Interventions Promoting Healthy Sexuality (NA)
- Improving Attentional and Cognitive Control in the Psychological Treatment of Intrusive Thoughts (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sulfamethazine CI brief — competitive landscape report
- Sulfamethazine updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Sulfamethazine
What is Sulfamethazine?
Sulfamethazine (sulfadimidine) is a sulfadimidine drug developed by Pfizer.
Who makes Sulfamethazine?
Sulfamethazine is developed and marketed by Pfizer (see full Pfizer pipeline at /company/pfizer).
What is the generic name of Sulfamethazine?
sulfadimidine is the generic (nonproprietary) name of Sulfamethazine.
What drug class is Sulfamethazine in?
Sulfamethazine belongs to the sulfadimidine class. See all sulfadimidine drugs at /class/sulfadimidine.
When was Sulfamethazine approved?
Sulfamethazine was first approved on 1949.
What development phase is Sulfamethazine in?
Sulfamethazine is FDA-approved (marketed).
What does Sulfamethazine target?
Sulfamethazine targets Lactoylglutathione lyase, Dihydropteroate synthase and is a sulfadimidine.
Related
- Drug class: All sulfadimidine drugs
- Target: All drugs targeting Lactoylglutathione lyase, Dihydropteroate synthase
- Manufacturer: Pfizer — full pipeline
- Therapeutic area: All drugs in Immunology